Home Clinical Topics FDA approves Lucentis for diabetic macular edema

FDA approves Lucentis for diabetic macular edema

Author(s):

On Aug. 10, the U.S. Food and Drug Administration (FDA) approved Lucentis (ranibizumab injection) for the treatment of diabetic macular edema. Read more.

LEAVE A REPLY

Please enter your comment!
Please enter your name here